You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 1, January 14, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (51)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Urinary Tract Disorders
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic

National Patterns in the Treatment of Urinary Tract Infections in Women by Ambulatory Care Physicians

Elbert S. Huang, MD, MPH; Randall S. Stafford, MD, PhD

Arch Intern Med. 2002;162:41-47.

Background  Trimethoprim-sulfamethoxazole has consistently been the recommended drug for uncomplicated urinary tract infections in women. Which antibiotics physicians use has implications for patient outcomes, antimicrobial resistance, and costs.

Methods  This study was based on a sample survey of practicing physicians participating in the National Ambulatory Medical Care Survey from 1989 through 1998. Eligible visits were limited to those by women aged 18 to 75 years diagnosed with uncomplicated acute cystitis or urinary tract infection (N = 1478). We evaluated trends in the proportions of visits at which physicians prescribed (1) trimethoprim-sulfamethoxazole, (2) recommended fluoroquinolones, (3) nitrofurantoin, and (4) nonrecommended antibiotics (neither trimethoprim-sulfamethoxazole nor recommended fluoroquinolones). We also identified predictors of specific antibiotic prescribing among visits to primary care physicians.

Results  The most frequently prescribed antibiotics were trimethoprim-sulfamethoxazole, recommended fluoroquinolones, and nitrofurantoin. We found that the proportion of trimethoprim-sulfamethoxazole prescriptions declined from 48% in 1989-1990 to 24% in 1997-1998 (adjusted odds ratio [OR], 0.33; 95% confidence interval [CI], 0.21-0.52 per decade). Conversely, fluoroquinolone use increased (19% to 29%) (OR, 2.28; 95% CI, 1.35-3.83) as did nitrofurantoin prescribing (14% to 30%) (OR, 2.44; 95% CI, 1.44-4.13). Among primary care physicians, internists were the most likely to prescribe fluoroquinolones while obstetricians were the most likely to use nitrofurantoin.

Conclusions  Ambulatory care physicians are increasing their use of fluoroquinolones and nitrofurantoin, even though they are not highly recommended and not the most cost-effective. Antibiotic prescribing in urinary tract infections may be influenced by clinical factors such as pregnancy and drug allergies but may also be shaped by nonclinical factors such as subspecialty culture.


From the General Medicine Division, University of Chicago, Chicago, Ill (Dr Huang); and the Stanford Center for Research in Disease Prevention, Stanford, Calif (Dr Stafford).


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2002;162(1):111.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk Factors for Trimethoprim-Sulfamethoxazole Resistance in Patients with Acute Uncomplicated Cystitis
Colgan et al.
Antimicrob. Agents Chemother. 2008;52:846-851.
ABSTRACT | FULL TEXT  

Validation of a Decision Aid to Assist Physicians in Reducing Unnecessary Antibiotic Drug Use for Acute Cystitis
McIsaac et al.
Arch Intern Med 2007;167:2201-2206.
ABSTRACT | FULL TEXT  

Short-Course Nitrofurantoin for the Treatment of Acute Uncomplicated Cystitis in Women
Gupta et al.
Arch Intern Med 2007;167:2207-2212.
ABSTRACT | FULL TEXT  

Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure
Wang et al.
J Antimicrob Chemother 2007;59:860-865.
ABSTRACT | FULL TEXT  

Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas
Wang et al.
Thorax 2006;61:903-908.
ABSTRACT | FULL TEXT  

Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study.
Karlowsky et al.
Antimicrob. Agents Chemother. 2006;50:2251-2254.
ABSTRACT | FULL TEXT  

Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture
Nys et al.
J Antimicrob Chemother 2006;57:955-958.
ABSTRACT | FULL TEXT  

Current antibiotic therapy for isolated urinary tract infections in women.
Kallen et al.
Arch Intern Med 2006;166:635-639.
ABSTRACT | FULL TEXT  

Acute Infections in Primary Care: Accuracy of Electronic Diagnoses and Electronic Antibiotic Prescribing
Linder et al.
J. Am. Med. Inform. Assoc. 2006;13:61-66.
ABSTRACT | FULL TEXT  

Antibiotic Treatment of Children With Sore Throat
Linder et al.
JAMA 2005;294:2315-2322.
ABSTRACT | FULL TEXT  

Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women: A Randomized Trial
Hooton et al.
JAMA 2005;293:949-955.
ABSTRACT | FULL TEXT  

Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study
Arredondo-Garcia et al.
J Antimicrob Chemother 2004;54:840-843.
ABSTRACT | FULL TEXT  

Changing Use of Antibiotics in Community-Based Outpatient Practice, 1991-1999
Steinman et al.
ANN INTERN MED 2003;138:525-533.
ABSTRACT | FULL TEXT  

Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
Karlowsky et al.
Antimicrob. Agents Chemother. 2002;46:2540-2545.
ABSTRACT | FULL TEXT  

Adherence to Evidence-Based Therapy: Some Practical Problems
Ghosh et al.
Arch Intern Med 2002;162:1310-1311.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.